The problem with being on the wrong side of a trade in reference to Sarepta is that every biotech company that has decided to file for Accelerate Approval and has been urged to file by the FDA has issued a Press Release when notified by the FDA that they should file for AA has stated that the FDA "urged the company that no other testing is necessary and your drug is approved" based on preliminary data that you have presented at the post-PhaseII data FDA meeting. Shorts... What do you think will happen to the share price when this gets announced? Double? Triple? How do you explain to your wives that you lost all your money???
You know that any AA announcement will have an announcement of manufacturing more drug along with it. This is a BIG decision whether or not to file. They won't file unless they're sure that this new manufacturing will be used when it comes on-line.